You are here:

MS in the media - 28 October 2016

Published on

22 - 28 October 2016

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

ECTRIMS video highlights

Highlights of the neurological meeting in London in September.  Clips include personalised decision making, long-term treatment effects, progressive MS research and imaging in clinical trials.  Also covers the late breaking news session that included siponimod, fampridine, fluoxetine and new treatment guidelines

Source: YouTube

MS Trust link: MS in the media - ECTRIMS 2016

MS in the modern treatment era

A study followed 471 people treated at an MS centre in California for ten years.  Most were on a disease modifying drug (though may have switched treatment during the period).  Two in five showed no worsening in disability over the study.  One in ten converted to secondary progressive MS, although studies done before disease modifying drugs were available suggested that the expected figure would be between one in three and one in two

Source: MS Research Australia

MS Trust link: MS Decisions - a guide to the disease modifying drugs for relapsing MS

Biotin study results

Research data for a potential treatment for progressive MS was presented at ECTRIMS and has now published in a journal.  One in eight people with secondary or primary progressive MS showed an improvement in disability (based on EDSS or 25 yard timed walk) after a year.  The figure was similar after the second year extension

Source: MS Research Australia

MS Trust link: Biotin (MD1003)

Nerves that affect postural control

A study found that damage to nerves in the pyramidal system (which controls muscle movements) had a greater effect on balance and posture than damage to the cerebellar system (which controls the coordination of movements).  Sensory impairment was less of a factor

Source: MS News Today

MS Trust link: Balance
MS Trust link: Posture

Print this page